Determination of applicationsS
This section has no associated Executive Note
3.—(1) In considering an application to which regulation 5(10) applies, the Board shall have regard to–
(a)the pharmaceutical services already provided in the neighbourhood of the premises named in the application by persons whose names are included in a pharmaceutical list;
(b)pharmaceutical services to be provided in the neighbourhood at these premises by any person whose name is included in the provisional pharmaceutical list;
(c)any representations received by the Board under paragraph 1;
(d)any information available to the Board which, in its opinion, is relevant to the consideration of the application; ...
[(e)any responses received in the 60 days following consultation in accordance with paragraph 2; and
(f)the pharmaceutical care services plan.]
(2) The Board may, in accordance with this Schedule, determine any application in such manner as it thinks fit and may, if it considers that oral representations are unnecessary, determine the application without hearing any oral representations.
(3) In any case in which the Board decides to hear oral representations, it shall give the applicant and any person from whom it received representations under paragraph 1 reasonable notice of the meeting at which such representations are to be heard.
(4) The applicant and any person mentioned in sub-paragraph (3) shall be permitted to be assisted in making representations at any such meeting by some other person, but that other person shall not appear in the capacity of counsel, solicitor or paid advocate, nor shall that person be entitled to speak on behalf of the applicant or any person mentioned in sub-paragraph (3).
(5) The procedure by which representations are heard shall be such as the Board may determine.
(6) The functions of the Board under this paragraph shall be exercised on behalf of the Board by the Pharmacy Practices Committee established within the terms of Part I of Schedule 4.
Textual Amendments
Commencement Information